Human Resources committee  Thank you very much, Mr. Chair. I appreciate the opportunity to present on behalf of the Association of Faculties of Medicine of Canada. I would suggest that you pick up the document I have here. There is some data that I'll be referring to and referencing in some of the slides.

Health committee  I speak from a physician's perspective, but we see a number of examples in the country that we need to build off. I think there are a few things in common, so I'll just mention two very quickly. You all know about the hip-and-knee study out of Alberta. How did they move from ma

Health committee  Yes, please, I would just like to add a few words. First, I have listened to the other presentations and I would like to refer you to the fourth recommendation of ours. We are trying to deal with that situation, in fact. That is, the federal government must play a leadership rol

Health committee  That's fine.

Health committee  Thank you. A couple of the asks are embedded in the slides, but I will be happy to formalize them in the way that Dr. Martin has suggested.

Health committee  On pathways to medical practice, we're talking about the need for a summit on pathways to practice. We think we should bring all the players together, the stakeholders, to exchange perspectives and try to rationalize the complex system of six assessment centres in a national stra

Health committee  That's great. Thank you.

Health committee  Thank you very much, Madam Chair. We did circulate a document that is my version of a PowerPoint presentation. I would ask you to perhaps follow along with me, because I'm going to refer to some data on it, and some of my comments may be a bit out of context unless you have it.

Finance committee  I agree there's a fair amount. In fact going back to the original questions, if you look at where research is done, the private sector in Canada does relatively less research when compared to many other jurisdictions, and there is larger support from our government. So I would ar

Finance committee  You've named three of them. There's a significant component about improving the efficiency of our system and how it works. There's a significant component around basic research. There's a significant component about population health and how we improve population.

Finance committee  CIHR is one of the organizations that's funded, and other organizations have appeared before you; the Heart and Stroke Foundation does funding, which should hopefully impact on heart disease. The other agencies will do some funding that has indirect impacts on health, if you're l

Finance committee  I personally, from my background as a family physician, share your perspective, and so does the association. What we're doing in medical school education is one of the direct ways of impacting on it, and most of the expansion in medical schools that I've alluded to is in distant

Finance committee  One quick fact, and then I'll give you a number. If you look at CIHR's funding compared with that of NIH, which is more or less a similar organization in the United States, and you adjust for population, CIHR has approximately one-third the funding that NIH has, adjusted for popu

Finance committee  No, I appreciate what you're saying. There are some very specific evaluators you can look at, and CIHR has developed some outcome measures that are flagged on their website. That's why I say you need a long-term vision. This is not about something you can measure in a year or t

Finance committee  In our view, there is clearly some urgency. Of the acceptable grants put before CIHR for funding, less than 25% were funded; that, to us, is a significant mark. My association is currently doing an assessment of what we describe as scientists at risk. They are both PhD scientis